Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ISRCTN17340368) titled 'A study testing new HIV treatment options for children and adolescents in Africa' on July 29.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Open (masking not used)
Control: Active
Assignment: Pragmatic open-label adaptive platform trial using the PRACTical design
Purpose: Health services research, Treatment
Primary Sponsor: University College London
Condition:
Human immunodeficiency virus (HIV)
Infections and Infestations
Intervention:
CHAPAS-5 uses a novel design called the Personalized Randomized Controlled Trial (PRACTical) design. This means that each participa...